Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ethanol extract of roasted licorice (EERL) is a botanical preparation derived from the roots of the licorice plant (typically *Glycyrrhiza uralensis* or *Glycyrrhiza glabra*) that have undergone a thermal roasting process. This processing significantly modifies the chemical composition of the root, notably converting the major saponin glycyrrhizin into glycyrrhetinic acid and increasing the concentration of non-polar bioactive components such as licochalcone A. EERL has demonstrated potent anti-carcinogenic and pro-apoptotic activities in various cancer cell lines. Its mechanism of action involves the induction of apoptosis through the activation of caspases and the modulation of Bcl-2 family proteins, as well as the inhibition of tumor cell proliferation. By reducing glycyrrhizin levels through roasting, EERL is studied as a potentially safer alternative to raw licorice extracts, aiming to minimize mineralocorticoid-related adverse effects such as hypertension and edema associated with interference in steroid metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ethanol extract of roasted licorice.